This message was sent to ##Email##
|
| December 25, 2019 |
| |  | | |
|
|
|
| |
|
As 2019 comes to a close, ASCT would like to wish its members, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of ASCT Viewpoint a look at the most accessed articles from the year. Our regular publication will resume Wednesday, Jan. 8.
|
CAP Today
From May 22: The tight supply of technologists to fill open positions is pushing laboratories to be creative in finding answers. Memorial Sloan Kettering Cancer Center and TriCore Reference Laboratories found their answers by looking not just outward but also — and largely — inward.
READ MORE
 |
|
EcoVue® was designed with patient safety in mind, our non-refillable and single use products will forever CHANGE YOUR VUE of ultrasound gel.
www.EcoVue.com
|
|
CAP Today
From Aug. 28: Cytology practice is shifting from fewer gynecologic screening tests to a greater focus on diagnostic testing in nongynecologic cytology including fine-needle aspiration. Roles of cytotechnologists have been changing in the workplace to help laboratories meet new demands and act as pathologist extenders. In many laboratories, cytotechnologists add efficiencies to pathology practice through their active roles in rapid on-site evaluation and preliminary evaluation of special stains and FISH testing.
READ MORE
Huffington Post
From May 8: Most sexually active women in the modern era know about human papillomavirus. Some were offered the HPV vaccine in their early teenage years and saw the ads all over television about reducing the risk of cervical cancer. But women aren't the only ones who contract HPV. According to the U.S. Centers for Disease Control and Prevention, 79 million American women and men are currently infected with HPV. And while awareness about how men can contract and spread the virus is increasing, there's still a gap between women and men when it comes to prevention and treatment. Simply put: Men aren't routinely tested like women are.
READ MORE
 |
|
The F-50 Non-Gyn Slide Processor has a liquid-based cytology system that features more cells per slide, and doesn’t need duplicate preps. The dual filtration disposable filters remove non-diagnostic material to optimize cell presentation. Cells of interest are transferred to the slide in a homogenous thin-layer cell deposit. Throughput: 50 samples/hr.
|
|
News-Medical.net
From Sept. 25: A new study reveals that rabbit and mice papilloma viruses are capable of spreading via contaminated blood from one to another. The study from Pennsylvania State researchers titled, "Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models" was published in the recent issue of the journal Emerging Microbes & Infections. The researchers warned that this study could be a basis for the hypothesis that HPV could also be transmitted between humans via blood.
READ MORE
JAMA Network
From July 24: Pathology is the study of disease. The practice of pathology in the U.S. is the application of all laboratory sciences to the prevention, diagnosis, treatment and follow-up of disease.
READ MORE
CAP Today
From July 10: The standard riff for talking about a promising new cancer test should be familiar to anyone within sneezing distance of a laboratory: There’s no one-size-fits-all assay.
READ MORE
CAP Today
From March 27: New data supports testing patients for their PD-L1 immune cell status when they are diagnosed with metastatic or unresectable locally advanced triple-negative breast cancer to determine if they might benefit from a checkpoint inhibitor.
READ MORE
HealthDay News via WebMD
From March 13: Infections with two strains of the sexually transmitted human papillomavirus are showing marked declines among American women, and rising vaccination rates could be driving the trend. That's the finding from a new study involving thousands of U.S. women who tested positive for precancerous conditions of the cervix.
READ MORE
CNN
From April 10: Prostate cancer, one of the deadliest forms of cancer for men in the U.S. and worldwide, is on the decline, according to new research.
READ MORE
The Economic Times
From Oct. 9: A new blood test has shown ability to screen numerous types of cancer with a high degree of accuracy. A trial of the test showed it detected and localized more than 20 types of cancers. The test, developed by biotechnology company Grail Inc uses next-generation sequencing technology to probe DNA for tiny chemical tags (methylation) that influence whether genes are active or inactive.
READ MORE
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
